RecruitingNCT05538806

TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study

TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study - TIGER Meso Study

Sponsor

NovoCure Ltd.

Enrollment

198 participants

Start Date

Aug 1, 2023

Study Type

OBSERVATIONAL

Conditions

Pleural Mesothelioma

Summary

The purpose of this post-authorisation medical device study is to obtain real life data on the use of Tumor Treating Fields (TTFields) in patients with pleural mesothelioma in routine clinical care. Patients with pleural mesothelioma and clinical indication for TTFields treatment will be enrolled in the study after signing Informed consent to use their data and process it centrally for research purposes. The clinical indication for TTFields is one of the inclusion criteria and is defined prior to inclusion by the treating physician.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting real-world data on a device called Tumor Treating Fields (TTFields), which uses low-intensity electrical fields delivered through a wearable device to disrupt cancer cell division. This specific version (NovoTTF-200T) is being used for patients with pleural mesothelioma, a rare cancer of the lining of the lung caused by asbestos exposure. The study tracks how well the device works in everyday clinical practice. **You may be eligible if:** - You are 18 years or older - You have been confirmed by biopsy to have pleural mesothelioma that cannot be surgically removed - Your doctor has already planned to use the NovoTTF-200T device as part of your treatment - Your life expectancy is more than 3 months - You consent to data collection **You may NOT be eligible if:** - You have already been using the NovoTTF-200T device for more than 1 week before enrolling Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETTFields

all patients will receive routine clinical care and TTFields

Locations(23)

Lungenklinik Gauting

Gauting, Bavaria, Germany

University Hospital Regensburg

Regensburg, Bavaria, Germany

Asklepios Klinikum Harburg

Harburg, Free and Hanseatic City of Hamburg, Germany

Klinikum Bremen-Ost

Bremen, Free Hanseatic City of Bremen, Germany

University Medicine Göttingen

Göttingen, Lower Saxony, Germany

University Hospital Carl Gustav Carus Dresden

Dresden, Saxony, Germany

Charité Universitätsmedizin Berlin

Berlin, Germany

Lungenklinik Heckeshorn

Berlin, Germany

Kliniken der Stadt Koeln

Cologne, Germany

Florence-Nightingale-Hospital

Düsseldorf, Germany

Klinikum Essen-Mitte

Essen, Germany

University Hospital Essen

Essen, Germany

Niels-Stensen Hospital

Georgsmarienhütte, Germany

Krankenhaus Martha-Maria Halle-Doelau

Halle, Germany

Medizinische Hochschule Hannover

Hanover, Germany

Lungenklinik Hemer

Hemer, Germany

Evangelisches Krankenhaus Herne

Herne, Germany

Krankenhaus Bethanien Moers

Moers, Germany

GEHO Muenster

Münster, Germany

Fachkliniken Wangen

Wangen, Germany

Azienda Ospedaliero-Universitaria di Alessandria "SS. Antonio e Biagio e C. Arrigo"

Alessandria, Italy

Humanitas Gavazzeni

Bergamo, Italy

Erasmus MC Cancer Centre

Rotterdam, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05538806

Related Trials

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

NCT063623695 locations

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

NCT0727741310 locations

INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)

NCT074036302 locations

The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma

NCT067900821 location

A Study of MT027 in Patients with Pleural Malignant Tumors

NCT067265641 location